Detalles de la búsqueda
1.
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study.
BMC Cancer
; 19(1): 611, 2019 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31227025
2.
Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post-metastatic survival: 35-year results from the Munich Cancer Registry.
J Cancer Res Clin Oncol
; 143(9): 1701-1712, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28429102
3.
Survival of de novo stage IV breast cancer patients over three decades.
J Cancer Res Clin Oncol
; 143(3): 509-519, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27853869
4.
Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.
Integr Cancer Ther
; 16(2): 165-175, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27627986
5.
Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.
Breast Care (Basel)
; 11(5): 315-322, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27920623
6.
Enhanced expression and activation of major matrix metalloproteinases in distinct topographic areas of invasive breast carcinomas.
Int J Oncol
; 26(5): 1203-7, 2005 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15809710
Resultados
1 -
6
de 6
1
Próxima >
>>